Overexpression of the epidermal growth factor receptor (EGFR) in primary tumors of prostate cancer and in high-grade gliomas, such as glioblastoma, often correlates with a poorer prognosis [15,16,17,18,19,20,21,22]. This evidence concerns the gene EGFR and prostate carcinoma.